The most mutated genes, which are associated with the development of resistance to targeted therapy in melanoma include CDKN2A [92,93], RB1 [92,94], PIK3CA, AKT3, HOXD8 [95], PAX5 [93], MAP3K8 [96], and MITF [95]. This evidence concerns the gene MITF and melanoma.